Screener
Amylyx Pharmaceuticals, Inc. AMLX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 201,434 | 90,328 |
| Prepaid expenses and other current assets | 5,578 | 6,692 |
| Total current assets | 256,338 | 323,671 |
| Property and equipment, net | 199 | 310 |
| Restricted cash equivalents | 986 | 985 |
| Operating lease right-of-use assets | 4,541 | 5,181 |
| Deposits and other assets | 2,500 | 2,498 |
| Total assets | $264,564 | $332,645 |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s PP&E (net)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported PP&E (net) of $199K in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s PP&E (net) decreased by 55.3% year-over-year, from $445K to $199K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s PP&E (net)?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s PP&E (net) has grown at a -10.1% compound annual growth rate (CAGR), from $474K to $310K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude